Le Lézard
Classified in: Health
Subjects: NPT, PSF, AVO

ISMP Encourages Adoption of Medication Error Reduction Plans


20 Year CA Effort Provides Framework to Advance Prevention Strategies  

PLYMOUTH MEETING, Pa., Nov. 30, 2022 /PRNewswire/ -- The Institute for Safe Medication Practices (ISMP) is sharing its support for California's Medication Error Reduction Plan (MERP) initiative in the hope that hospital regulators and accreditors, if not U.S. hospitals themselves, will voluntarily adopt similar programs.

ISMP has always been an advocate for learning from the experiences of others. Since 2002, the California Department of Public Health has required every licensed general, acute care hospital to establish a MERP. The CA MERP provides a framework to advance many of the error reduction strategies that ISMP has advocated for and supported, including:

"While ISMP realizes that resources and expertise are necessary to design and execute a robust MERP, these efforts can significantly improve safety," says ISMP President Rita K. Jew, PharmD, MBA, BCPPS, FASHP. "We encourage hospitals and health systems working outside of CA to complete a gap analysis using the framework and develop a formal MERP that focuses on high-leverage systems and technologies to improve high-alert medication processes."

To oversee the CA MERP, each organization must designate an interdisciplinary medication safety committee comprised of pharmacists, nurses, physicians, and administrators. Coordination of the committee's activities by a medication safety officer (MSO) is highly recommended.

For more information on ISMP's Medication Safety Officer Society (MSOS), which offers an open forum for information sharing and collaboration, visit: Medication Safety Officers Society- MSOS | (medsafetyofficer.org). To access a copy of ISMP's white paper on MSOs, go to: A Recurring Call to Action: Every Healthcare Organization Needs a Medication Safety Officer! | Institute For Safe Medication Practices (ismp.org)

For a detailed summary of the required components in each hospital's CA MERP, sample self assessment questions, and examples of initiatives organizations could implement as part of their own programs, visit: California Medication Error Reduction Plan: Time for Regulators and Accreditors to Adopt Similar Initiatives | Institute For Safe Medication Practices (ismp.org)

About the Institute for Safe Medication Practices

The Institute for Safe Medication Practices (ISMP) is the nation's first 501c (3) nonprofit organization devoted entirely to preventing medication errors. ISMP is known and respected for its medication safety information. For more than 25 years, it also has served as a vital force for progress. ISMP's advocacy work alone has resulted in numerous necessary changes in clinical practice, public policy, and drug labeling and packaging. Among its many initiatives, ISMP runs the only national voluntary practitioner medication error reporting program, publishes newsletters with real-time error information read and trusted throughout the global healthcare community, and offers a wide range of unique educational programs, tools, and guidelines. In 2020, ISMP formally affiliated with ECRI to create one of the largest healthcare quality and safety entities in the world, and ECRI and the ISMP PSO is a federally certified patient safety organization by the U.S. Department of Health and Human Services. As an independent watchdog organization, ISMP receives no advertising revenue and depends entirely on charitable donations, educational grants, newsletter subscriptions, and volunteer efforts to pursue its life-saving work. Visit www.ismp.org and follow @ismp_org to learn more.

SOURCE Institute for Safe Medication Practices


These press releases may also interest you

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...

at 07:30
During an awards ceremony to present the 2024 list of Best Workplacestm in Canada, Great Place to Work® announced the 50 Best Workplacestm in Canada with 100-999 employees....

at 07:05
At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays. Simplifying...



News published on and distributed by: